You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

allo-HSCT

Showing 1 - 25 of 1,192
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Leukemia, MDS Trial (IFN-?)

Not yet recruiting
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Nov 15, 2023

Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

Recruiting
  • Hematologic Malignancy
  • Stem Cell Transplant Complications
  • Beijing protocol
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Jun 19, 2023

Immune Reconstitution After Allo-HSCT and Blinatumomab

Not yet recruiting
  • Leukemia, Lymphoid
  • (no location specified)
Oct 3, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

Recruiting
  • Hematopoietic Malignancy
  • +2 more
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Nov 6, 2023

Brain Neuronal Networks, Chemosensory and Trigeminal Functions

Recruiting
  • Hematopoietic Stem Cell Transplantation
    • Oslo, Norway
      University of Oslo
    Aug 21, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    Alterations in Intestinal Microbiota, Metabolites, and Immune

    Recruiting
    • Graft Vs Host Disease
    • Blood Sample
    • +2 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Nov 16, 2023

    Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)

    Recruiting
    • Acute Myeloid Leukemia
    • allogenic NK cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 27, 2023

    Prophylactic HQP1351 Therapy, Third Generation TKI Trial in Guanzhou (HQP1351( Olverembatinib dimesylate))

    Withdrawn
    • Prophylactic HQP1351 Therapy
    • Third Generation TKI
    • HQP1351( Olverembatinib dimesylate)
    • Guanzhou, China
      Department of Hematology, Nanfang Hospital, Southern Medical Uni
    Jan 16, 2023

    Acute Myeloid Leukemia Trial in Hefei (RC1012 injection (allo-DNT cells))

    Recruiting
    • Acute Myeloid Leukemia
    • RC1012 injection (allo-DNT cells)
    • Hefei, Anhui, China
      The First Hospital of the University of Science and Technology o
    May 17, 2023

    Leukemia, Lymphoid Trial in Chengdu (blinatumomab)

    Not yet recruiting
    • Leukemia, Lymphoid
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Oct 3, 2023

    Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

    Active, not recruiting
    • Relapsed Adult ALL
    • Relapsed Adult AML
    • Changchun, Jilin, China
      First Hospital of Jilin University
    Nov 19, 2023

    Leukemia Trial (Prehabilitation)

    Not yet recruiting
    • Leukemia
    • Prehabilitation
    • (no location specified)
    Dec 5, 2022

    Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Jun 8, 2023

    Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • +3 more
    • Venetoclax plus RIC
    • Shanghai, Shanghai, China
      Shanghai General Hospital
    Oct 12, 2022

    MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)

    Not yet recruiting
    • MPS-IH (Hurler Syndrome)
    • Experimental: OTL-203
    • Active Comparator: Allo-HSCT
    • Oakland, California
    • +6 more
    Nov 27, 2023

    Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

    Recruiting
    • Myeloid Malignancies
    • fractionated busulfan-based conditioning regimen
    • Chendu, Sichuan, China
      West China Hospital, Sichuan University
    Mar 29, 2023

    The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or

    Recruiting
    • Acute Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 28, 2022

    CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

    Not yet recruiting
    • CMV Infection
    • +2 more
    • Virus specific T cells
    • (no location specified)
    Oct 4, 2023

    The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

    Recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 25, 2022

    The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

    Recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 25, 2022

    Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Mar 15, 2023

    Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Dec 27, 2022